Jianfeng Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianfeng Dai has a total of 196 co-authors. Here are the top co-authors by number of shared publications:
Wen Pan
Children’s Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China
14 shared publicationsTingting Feng
Central Laboratory, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China
13 shared publicationsChenxiao Huang
Children’s Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China
10 shared publications- Tingting Feng
Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou, China
9 shared publications Jinyu Zhang
Jiangsu Key Laboratory of Infection and Immunity, Children's Hospital of Soochow University, Institute of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Suzhou 215123, China; Central Laboratory, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
8 shared publicationsXia Zhou
School of Basic Medicine, Suzhou Medical College of Soochow University, Suzhou, China
8 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
Construction of an SFTSV ΔN reporter pseudovirus for antiviral drug screening
- 15 October 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
Open AccessConstruction of an SFTSV ΔN reporter pseudovirus for antiviral drug screening
- 19 January 2026
- Published by Wiley in Insect Science
Gut microbiota landscape of Haemaphysalis longicornis under Borrelia burgdorferi infection
This study aimed to explore the reason for Haemaphysalis longicornis restricting Borrelia burgdorferi colonization and transmission from the perspective of gut microbiota, and to investigate the impact of different infection statuses on the Haemaphysalis longicornis microbiota and its potential role in pathogen transmission. Pathogen‐free Haemaphysalis longicornis ticks and IFNAR1 −/− mice were used to establish infection models. Ticks fed on pathogen‐infected mice, and their midguts were analyzed at day 4 and 10 post‐feeding. DNA was extracted from the midguts, and the V3–V4 region of bacterial 16S rRNA gene was amplified and sequenced. Analysis of microbiome data were analyzed using QIIME2 and R. After digesting the bloodmeals, the gut microbiota of ticks that ingested bloodmeal with Borrelia burgdorferi exhibited minimal structural changes, while the ticks with uninfected bloodmeal or bloodmeal with Langat virus showed the dysbiosis. The Borrelia group showed minimal temporal shifts in β ‐diversity, with stable co‐occurrence networks and increased core microbial interactions. Neutral model analysis revealed a hybrid niche in the Borrelia group. Potential biomarkers were identified that may suppress Borrelia burgdorferi transmission. Our findings reveal that Borrelia burgdorferi infection is associated with a stabilized and functionally distinct gut microbiota in Haemaphysalis longicornis . The gut microbiota of Haemaphysalis longicornis functions as a barrier against Borrelia burgdorferi colonization and transmission through microbial regulation and resource limitation, thus providing a potential mechanistic explanation for the observed vector incompetence. These findings highlight the potential of microbiome‐targeted strategies to block pathogen transmission and offer new insights into vector‐borne disease.
- 19 January 2026
- Published by Wiley in Insect Science
Gut microbiota landscape of Haemaphysalis longicornis under Borrelia burgdorferi infection
This study aimed to explore the reason for Haemaphysalis longicornis restricting Borrelia burgdorferi colonization and transmission from the perspective of gut microbiota, and to investigate the impact of different infection statuses on the Haemaphysalis longicornis microbiota and its potential role in pathogen transmission. Pathogen‐free Haemaphysalis longicornis ticks and IFNAR1 −/− mice were used to establish infection models. Ticks fed on pathogen‐infected mice, and their midguts were analyzed at day 4 and 10 post‐feeding. DNA was extracted from the midguts, and the V3–V4 region of bacterial 16S rRNA gene was amplified and sequenced. Analysis of microbiome data were analyzed using QIIME2 and R. After digesting the bloodmeals, the gut microbiota of ticks that ingested bloodmeal with Borrelia burgdorferi exhibited minimal structural changes, while the ticks with uninfected bloodmeal or bloodmeal with Langat virus showed the dysbiosis. The Borrelia group showed minimal temporal shifts in β ‐diversity, with stable co‐occurrence networks and increased core microbial interactions. Neutral model analysis revealed a hybrid niche in the Borrelia group. Potential biomarkers were identified that may suppress Borrelia burgdorferi transmission. Our findings reveal that Borrelia burgdorferi infection is associated with a stabilized and functionally distinct gut microbiota in Haemaphysalis longicornis . The gut microbiota of Haemaphysalis longicornis functions as a barrier against Borrelia burgdorferi colonization and transmission through microbial regulation and resource limitation, thus providing a potential mechanistic explanation for the observed vector incompetence. These findings highlight the potential of microbiome‐targeted strategies to block pathogen transmission and offer new insights into vector‐borne disease.
- Open Access
- 15 October 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2570000
Human bocavirus NP1 antagonizes host type I interferon response through repressing the nuclear transport of STAT1
Human bocavirus 1 (HBoV1), first identified in human nasopharyngeal specimens in 2005, is a relatively recent member of the respiratory virus family and is primarily associated with respiratory tract infections. Despite this, the mechanisms underlying HBoV1 pathogenesis remain poorly understood, primarily due to the lack of suitable cell lines and animal models, as well as the complicating factor of co-infections with other pathogens. In this study, we demonstrate that the non-structural protein 1 (NP1) of HBoV1 antagonizes the type I interferon (IFN-I) signaling pathway. NP1 interacts with the DNA-binding domain (DBD) of signal transducer and activator of transcription 1 (STAT1) and the importing β-binding (IBB) domain of karyopherin subunit alpha-1 (KPNA1), thereby disrupting the formation of the STAT1/KPNA1/KPNB1 complex and subsequently inhibiting STAT1 nuclear translocation, a critical step in IFN-I signaling. Furthermore, we show that HBoV1 NP1 facilitates the replication of influenza A virus (IAV) and respiratory syncytial virus (RSV). These findings suggest a novel mechanism by which bocavirus proteins antagonize the host's innate immune response and provide new evidence that bocavirus may exacerbate the symptoms of clinical respiratory viral infections.
- 15 October 2025
- Published by Taylor & Francis in Virulence
- Vol. 16 (1) , 2570000
Open AccessHuman bocavirus NP1 antagonizes host type I interferon response through repressing the nuclear transport of STAT1
Human bocavirus 1 (HBoV1), first identified in human nasopharyngeal specimens in 2005, is a relatively recent member of the respiratory virus family and is primarily associated with respiratory tract infections. Despite this, the mechanisms underlying HBoV1 pathogenesis remain poorly understood, primarily due to the lack of suitable cell lines and animal models, as well as the complicating factor of co-infections with other pathogens. In this study, we demonstrate that the non-structural protein 1 (NP1) of HBoV1 antagonizes the type I interferon (IFN-I) signaling pathway. NP1 interacts with the DNA-binding domain (DBD) of signal transducer and activator of transcription 1 (STAT1) and the importing β-binding (IBB) domain of karyopherin subunit alpha-1 (KPNA1), thereby disrupting the formation of the STAT1/KPNA1/KPNB1 complex and subsequently inhibiting STAT1 nuclear translocation, a critical step in IFN-I signaling. Furthermore, we show that HBoV1 NP1 facilitates the replication of influenza A virus (IAV) and respiratory syncytial virus (RSV). These findings suggest a novel mechanism by which bocavirus proteins antagonize the host's innate immune response and provide new evidence that bocavirus may exacerbate the symptoms of clinical respiratory viral infections.
- 15 April 2025
- Published by Elsevier in Cellular Signalling
- Vol. 132, 111807
Hedgehog pathway inhibitor HhAntag suppresses virus infection via the GLI-S1PR axis
- 15 April 2025
- Published by Elsevier in Cellular Signalling
- Vol. 132, 111807
Hedgehog pathway inhibitor HhAntag suppresses virus infection via the GLI-S1PR axis
- Open Access
- 26 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Identification of antiviral RNAi regulators, ILF3/DHX9, recruit at ZIKV stem loop B to protect against ZIKV induced microcephaly
Zika virus (ZIKV) is a member of the Flaviviridae family and causes congenital microcephaly and Guillain–Barré syndrome. Currently, there is a lack of approved vaccines or therapies against ZIKV infection. In this study, we profile vRNA‒host protein interactomes at ZIKV stem‒loop B (SLB) and reveal that interleukin enhancer binding factor 3 (ILF3) and DEAH-box helicase 9 (DHX9) form positive regulators of antiviral RNA inference in undifferentiated human neuroblastoma cells and induced pluripotent stem cell-derived human neural stem cells (iPSC–NSCs). Functionally, ablation of ILF3 in brain organoids and Nestin-Cre ILF3 cKO foetal mice significantly enhance ZIKV replication and aggravated ZIKV-induced microcephalic phenotypes. Mechanistically, ILF3/DHX9 enhance DICER processing of ZIKV vRNA-derived siRNAs (vsiR-1 and vsiR-2) to exert anti-flavivirus activity. VsiR-1 strongly inhibits ZIKV NS5 polymerase activity and RNA translation. Treatment with the vsiR-1 mimic inhibits ZIKV replication in vitro and in vivo and protected mice from ZIKV-induced microcephaly. Overall, we propose a novel therapeutic strategy to combat flavivirus infection.
- 26 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessIdentification of antiviral RNAi regulators, ILF3/DHX9, recruit at ZIKV stem loop B to protect against ZIKV induced microcephaly
Zika virus (ZIKV) is a member of the Flaviviridae family and causes congenital microcephaly and Guillain–Barré syndrome. Currently, there is a lack of approved vaccines or therapies against ZIKV infection. In this study, we profile vRNA‒host protein interactomes at ZIKV stem‒loop B (SLB) and reveal that interleukin enhancer binding factor 3 (ILF3) and DEAH-box helicase 9 (DHX9) form positive regulators of antiviral RNA inference in undifferentiated human neuroblastoma cells and induced pluripotent stem cell-derived human neural stem cells (iPSC–NSCs). Functionally, ablation of ILF3 in brain organoids and Nestin-Cre ILF3 cKO foetal mice significantly enhance ZIKV replication and aggravated ZIKV-induced microcephalic phenotypes. Mechanistically, ILF3/DHX9 enhance DICER processing of ZIKV vRNA-derived siRNAs (vsiR-1 and vsiR-2) to exert anti-flavivirus activity. VsiR-1 strongly inhibits ZIKV NS5 polymerase activity and RNA translation. Treatment with the vsiR-1 mimic inhibits ZIKV replication in vitro and in vivo and protected mice from ZIKV-induced microcephaly. Overall, we propose a novel therapeutic strategy to combat flavivirus infection.
- 3 February 2025
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (4) , 277-287
Tumor Microenvironment: Obstacles and Opportunities for T Cell–Based Tumor Immunotherapies
The complex composition and dynamic change of the tumor microenvironment (TME), mainly consisting of tumor cells, immune cells, stromal cells, and extracellular components, significantly impede the effector function of cytotoxic T lymphocytes (CTL), thus representing a major obstacle for tumor immunotherapies. In this review, we summarize and discuss the impacts and underlying mechanisms of major elements in the TME (different cell types, extracellular matrix, nutrients and metabolites, etc.) on the infiltration, survival, and effector functions of T cells, mainly CD8+ CTLs. Moreover, we also highlight recent advances that may potentiate endogenous antitumor immunity and improve the efficacy of T cell–based immunotherapies in patients with cancer by manipulating components inside/outside of the TME. A deeper understanding of the effects and action mechanisms of TME components on the tumor-eradicating ability of CTLs may pave the way for discovering new targets to augment endogenous antitumor immunity and for designing combinational therapeutic regimens to enhance the efficacy of tumor immunotherapies in the clinic.
- 3 February 2025
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (4) , 277-287
Tumor Microenvironment: Obstacles and Opportunities for T Cell–Based Tumor Immunotherapies
The complex composition and dynamic change of the tumor microenvironment (TME), mainly consisting of tumor cells, immune cells, stromal cells, and extracellular components, significantly impede the effector function of cytotoxic T lymphocytes (CTL), thus representing a major obstacle for tumor immunotherapies. In this review, we summarize and discuss the impacts and underlying mechanisms of major elements in the TME (different cell types, extracellular matrix, nutrients and metabolites, etc.) on the infiltration, survival, and effector functions of T cells, mainly CD8+ CTLs. Moreover, we also highlight recent advances that may potentiate endogenous antitumor immunity and improve the efficacy of T cell–based immunotherapies in patients with cancer by manipulating components inside/outside of the TME. A deeper understanding of the effects and action mechanisms of TME components on the tumor-eradicating ability of CTLs may pave the way for discovering new targets to augment endogenous antitumor immunity and for designing combinational therapeutic regimens to enhance the efficacy of tumor immunotherapies in the clinic.
- Open Access
- 25 November 2024
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 20 (11) , e1012725
N6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection
Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a novel bunyavirus primarily transmitted by Haemaphysalis longicornis, induces severe disease with a high mortality rate. N6-methyladenosine (m6A) is a prevalent internal chemical modification in eukaryotic mRNA that has been reported to regulate viral infection. However, the role of m6A modification during SFTSV infection remains elusive. We here reported that SFTSV RNAs bear m6A modification during infection. Manipulating the expressions or activities of host m6A regulators significantly impacted SFTSV infection. Mechanistically, SFTSV recruited m6A regulators through the nucleoprotein to modulate the m6A modification of viral RNA, eventually resulting in enhanced infection by promoting viral mRNA translation efficiency and/or genome RNA stability. m6A mutations in the S genome diminished virus particle production, while m6A mutations in the G transcript impaired the replication of recombinant vesicular stomatitis virus (rVSV) expressing G protein in vitro and in vivo. Interestingly, m6A modification was evolutionarily conserved and facilitated SFTSV infection in primary tick cells. These findings may open an avenue for the development of m6A-targeted anti-SFTSV vaccines, drugs, and innovative strategies for the prevention and control of tick-borne disease.
- 25 November 2024
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 20 (11) , e1012725
Open AccessN6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection
Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a novel bunyavirus primarily transmitted by Haemaphysalis longicornis, induces severe disease with a high mortality rate. N6-methyladenosine (m6A) is a prevalent internal chemical modification in eukaryotic mRNA that has been reported to regulate viral infection. However, the role of m6A modification during SFTSV infection remains elusive. We here reported that SFTSV RNAs bear m6A modification during infection. Manipulating the expressions or activities of host m6A regulators significantly impacted SFTSV infection. Mechanistically, SFTSV recruited m6A regulators through the nucleoprotein to modulate the m6A modification of viral RNA, eventually resulting in enhanced infection by promoting viral mRNA translation efficiency and/or genome RNA stability. m6A mutations in the S genome diminished virus particle production, while m6A mutations in the G transcript impaired the replication of recombinant vesicular stomatitis virus (rVSV) expressing G protein in vitro and in vivo. Interestingly, m6A modification was evolutionarily conserved and facilitated SFTSV infection in primary tick cells. These findings may open an avenue for the development of m6A-targeted anti-SFTSV vaccines, drugs, and innovative strategies for the prevention and control of tick-borne disease.
- 22 November 2024
- Published by Elsevier in Insect Biochemistry and Molecular Biology
- Vol. 176, 104218
The immune function of thioester-containing proteins in typical invertebrate disease vectors
- 22 November 2024
- Published by Elsevier in Insect Biochemistry and Molecular Biology
- Vol. 176, 104218
The immune function of thioester-containing proteins in typical invertebrate disease vectors
- 22 October 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (10) , e0118324
Envelope domain III E 324 , E 351 , and E 380 mutations lever adaptive evolution of DENV-1 genotype I
Dengue virus (DENV) gains genetic mutations during continuous transmission and evolution, making the virus more adaptive and virulent. The clade of DENV-1 genotype I has expanded and become the predominant genotype in Asia and the Pacific areas, but the underlying mechanisms are unclear. A combined analysis of nonsynonymous mutations in domain III of the envelope protein and their biological effects on virus pathogenesis and transmission was evaluated. Phylogenetic analyses found three nonsynonymous mutations (V324I, V351L, and V380I) in domain III of the envelope protein, which emerged in 1970s–1990s and stably inherited and expanded in contemporary strains after 2000. We generated reverse-mutated viruses (I324V, L351V, and I380V) based on an infectious clone of an epidemic DENV-1 strain (NIID02–20), and the results suggested that the infectivity of the contemporary epidemic virus (wild type, WT) has increased compared to the reverse mutant viruses in mammalian hosts but not mosquito vectors. The WT virus showed a higher binding affinity to host cells and increased virion stability. In addition, weaker immunogenicity and higher resistance to neutralizing antibodies of the WT virus indicated a trend of immune escape. The data suggested that nonsynonymous mutations of the E protein (V324I, V351L, and V380I) promote infectivity and immune evasion of DENV-1 genotype I, which may facilitate its onward transmission on a global scale. IMPORTANCE: We provide evidence that minor sequence variation among dengue virus (DENV) strains can result in increased adaptability and virulence, impacting both the biology of the virus and the antiviral immune response. The genetic mutations of DENV-1 gained during continuous transmission and evolution will offer new clues for the design of novel vaccines against flaviviruses.
- 22 October 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (10) , e0118324
Envelope domain III E 324 , E 351 , and E 380 mutations lever adaptive evolution of DENV-1 genotype I
Dengue virus (DENV) gains genetic mutations during continuous transmission and evolution, making the virus more adaptive and virulent. The clade of DENV-1 genotype I has expanded and become the predominant genotype in Asia and the Pacific areas, but the underlying mechanisms are unclear. A combined analysis of nonsynonymous mutations in domain III of the envelope protein and their biological effects on virus pathogenesis and transmission was evaluated. Phylogenetic analyses found three nonsynonymous mutations (V324I, V351L, and V380I) in domain III of the envelope protein, which emerged in 1970s–1990s and stably inherited and expanded in contemporary strains after 2000. We generated reverse-mutated viruses (I324V, L351V, and I380V) based on an infectious clone of an epidemic DENV-1 strain (NIID02–20), and the results suggested that the infectivity of the contemporary epidemic virus (wild type, WT) has increased compared to the reverse mutant viruses in mammalian hosts but not mosquito vectors. The WT virus showed a higher binding affinity to host cells and increased virion stability. In addition, weaker immunogenicity and higher resistance to neutralizing antibodies of the WT virus indicated a trend of immune escape. The data suggested that nonsynonymous mutations of the E protein (V324I, V351L, and V380I) promote infectivity and immune evasion of DENV-1 genotype I, which may facilitate its onward transmission on a global scale. IMPORTANCE: We provide evidence that minor sequence variation among dengue virus (DENV) strains can result in increased adaptability and virulence, impacting both the biology of the virus and the antiviral immune response. The genetic mutations of DENV-1 gained during continuous transmission and evolution will offer new clues for the design of novel vaccines against flaviviruses.
- Open Access
- 20 September 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (1) , 110-126
Harnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery
Background and Aims: Hyperactivated inflammatory responses induced by cytokine release syndrome are the primary causes of tissue damage and even death. The translation process is precisely regulated to control the production of proinflammatory cytokines. However, it is largely unknown whether targeting translation can effectively limit the hyperactivated inflammatory responses during acute hepatitis and graft-versus-host disease. Approach and Results: By using in vitro translation and cellular overexpression systems, we have found that the nonstructural protein gene NS2A of Zika virus functions as RNA molecules to suppress the translation of both ectopic genes and endogenous proinflammatory cytokines. Mechanistically, results from RNA pulldown and co-immunoprecipitation assays have demonstrated that NS2A RNA interacts with the translation initiation factor eIF2α to disrupt the dynamic balance of the eIF2/eIF2B complex and translation initiation, which is the rate-limiting step of translation. In the acetaminophen-induced, lipopolysaccharide/D-galactosamine-induced, viral infection-induced acute hepatitis, and graft-versus-host disease mouse models, mice with myeloid cell-specific knock-in of NS2A show decreased levels of serum proinflammatory cytokines and reduced tissue damage. Conclusions: Zika virus NS2A dampens the production of proinflammatory cytokines and alleviates inflammatory injuries by interfering translation process as RNA molecules, which suggests that NS2A RNA is potentially used to treat numerous acute inflammatory diseases characterized by cytokine release syndrome.
- 20 September 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (1) , 110-126
Open AccessHarnessing ZIKV NS2A RNA for alleviating acute hepatitis and cytokine release storm by targeting translation machinery
Background and Aims: Hyperactivated inflammatory responses induced by cytokine release syndrome are the primary causes of tissue damage and even death. The translation process is precisely regulated to control the production of proinflammatory cytokines. However, it is largely unknown whether targeting translation can effectively limit the hyperactivated inflammatory responses during acute hepatitis and graft-versus-host disease. Approach and Results: By using in vitro translation and cellular overexpression systems, we have found that the nonstructural protein gene NS2A of Zika virus functions as RNA molecules to suppress the translation of both ectopic genes and endogenous proinflammatory cytokines. Mechanistically, results from RNA pulldown and co-immunoprecipitation assays have demonstrated that NS2A RNA interacts with the translation initiation factor eIF2α to disrupt the dynamic balance of the eIF2/eIF2B complex and translation initiation, which is the rate-limiting step of translation. In the acetaminophen-induced, lipopolysaccharide/D-galactosamine-induced, viral infection-induced acute hepatitis, and graft-versus-host disease mouse models, mice with myeloid cell-specific knock-in of NS2A show decreased levels of serum proinflammatory cytokines and reduced tissue damage. Conclusions: Zika virus NS2A dampens the production of proinflammatory cytokines and alleviates inflammatory injuries by interfering translation process as RNA molecules, which suggests that NS2A RNA is potentially used to treat numerous acute inflammatory diseases characterized by cytokine release syndrome.